Top

Oral Cancer

Published in:

01-06-2018 | Original Article

Oral and oropharyngeal cancer in Colombia: an experience in a middle-income country cancer institute (2004–2013)

Authors: Constanza Pardo, Esther de Vries

Published in: Oral Cancer | Issue 1-2/2018

Abstract

Aims

To provide demographical and clinical characteristics and estimations of 2-year overall survival (OS) of oral and oropharyngeal cancer (OOC) patients treated in the Colombian National Cancer Institute (INC) between 2004 and 2013.

Methods

All 1108 patients first treated at INC for OOC in the three periods, without a prior cancer diagnosis, were included in this study. The INC hospital-based cancer registry was cross-linked with governmental databases to obtain follow-up information on all patients. Probability of surviving 24 months since the date of entry at INC was estimated using Kaplan–Meier methods, using the log-rank test to evaluate differences between groups. In order to evaluate the relative effect of age, sex, clinical stage, anatomical site and type of health insurance on survival, we constructed a multivariate Cox proportional hazard model.

Results

The overall survival probability at 24 months was 48.2% (95% CI 45.3; 51.1), which was stable over time. Advanced age and clinical stage substantially affected overall survival, being 30.3% (95% CI 25.2; 35.4) for age > 70 and 34.7% (95% CI 29.4; 40.0) for stage IV disease. Hazard ratios were significantly higher for patients aged 70 and over [HR 1.99 (95% CI 1.41–2.79)] and advanced stage cancers [HR 2.16 (95% CI 1.55–3.01)], whereas patients with cancers of the tonsils or salivary glands had a strongly reduced risks compared to tongue and oral cavity cancer [HR 0.56 (95% CI 0.43–0.72)].

Conclusions

Oral and oropharyngeal cancer has a very poor prognosis which was stable over time. Considering the late stage at diagnosis, much can be gained by improving early detection and treatment.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. https://doi.org/10.1002/ijc.29210 (E pub 2014 Oct 9) CrossRefPubMed

Perdomo S, Martin Roa G, Brennan P, Forman D, Sierra MS (2015) Head and neck cancer burden and preventive measures in Central and South America. Cancer Epidemiol 44(Suppl 1):S43–S52. https://doi.org/10.1016/j.canep.2016.03.012

Curado MP, Johnson NW, Kerr AR, Rodrigues D, Lanfranchi H, Lima D et al (2016) Oral and oropharynx cancer in South America: incidence, mortality trends and gaps in public databases as presented to the Global Oral Cancer Forum. Trans Res Oral Oncol 1:1–7. https://doi.org/10.1177/2057178X16653761

Pardo C, Cendales R (2015) Incidencia, mortalidad y prevalencia de cáncer en Colombia, 2007–2011. Primera edición. Instituto Nacional de Cancerología, Bogotá. http://www.cancer.gov.co/publicaciones?idpadre=1&idcategoria=59. Accessed 24 Nov 2016

Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45(4-5):309–316. https://doi.org/10.1016/j.oraloncology.2008.06.002 (E pub 2008 Sep 18) CrossRefPubMed

Wong YK, Tsai WC, Lin JC, Poon CK, Chao SY, Hsiao YL, Chan MY, Cheng CS, Wang CC, Wang CP, Liu SA (2006) Socio-demographic factors in the prognosis pf oral cancer patients. Oral Oncol 42(9):893–906. https://doi.org/10.1016/j.oraloncology.2005.12.007 (E pub 2006 May 26) CrossRefPubMed

Guerrero R, Gallego AI, Becerril-Montekio V, Vásquez J (2011) Sistema de salud de Colombia. Salud pública Méx 53(suppl 2):s144–s155. http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342011000800010&lng=es&tlng=es. Accessed 24 Nov 2016

Ministerio de Salud y Protección Social (2015) Informe al Congreso de la República 2014–2015. Sector Administrativo de Salud y Protección Social. D.C: MinSalud, Bogotá. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/PES/informe-congreso-2014-2015.pdf. Accessed 24 Nov 2016

Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS et al (2015) Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972):977–1010. https://doi.org/10.1016/S0140-6736(14)62038-9 (E pub 2014 Nov 26) CrossRefPubMed

10.

Ordoñez D, Aragón N, García LS, Collazos PA, Bravo LE (2014) Cáncer oral en Santiago de Cali, Colombia: análisis poblacional de la tendencia de incidencia y mortalidad. Salud pública Méx 56(5):465–472CrossRefPubMed

11.

Carneseca EC, Mauad EC, de Araujo MAA, Dalbó RM, Longatto Filho A, de Lima Vazquez V (2013) The Hospital de Câncer de Barretos Registry: an analysis of cancer survival at a single institution in Brazil over a 10-year period. BMC Res Notes 6:141. https://doi.org/10.1002/ijc.25516ID CrossRefPubMedPubMedCentral

12.

Leite ICG, Koifman S (1998) Survival analysis in a sample of oral cancer patients at a reference hospital in Rio de Janeiro, Brazil. Oral Oncol 34(5):347–352CrossRefPubMed

13.

Pardo C, de Vries E, Acero D, Murillo R (2015) Vigilancia de la supervivencia global por cáncer en Colombia: utilidad de los registros rutinarios. Rev Colomb Cancerol 19(2):81–89. https://doi.org/10.1016/j.rccan.2015.03.001

14.

Pardo C, de Vries E (2017) Supervivencia global de pacientes con cáncer en el Instituto Nacional de Cancerología (INC). Rev Colomb Cancerol 21(1):12–18. https://doi.org/10.1016/j.rccan.2017.01.003

15.

Instituto Nacional de Cancerología (2017) Registro institucional de cáncer [Bases de datos]. INC, Bogotá

16.

Registraduría Nacional del Estado Civil (2012) Manual de usuario del aplicativo de expedición de certificados de vigencia de cédula. Registraduría Nacional del Estado Civil. https://wsp.registraduria.gov.co/certificado/?AspxAutoDetectCookieSupport=1. Accessed 26 June 2017

17.

World Health Organization (2003) International classification of diseases for oncology ICD-O-3. WHO, International Agency for Research on Cancer

18.

Kumar M, Nanavati R, Modi TG, Dobariya C (2016) Oral cancer: etiology and risk factors: a review. J Can Res Ther 12(2):458–463. https://doi.org/10.4103/0973-1482.186696 CrossRef

19.

Le Campion ACOV, Ribeiro CMB, Luiz RR, da Silva Junior FF, Barros HCS, Dos Santos KCB et al (2017) Low Survival rates of oral and oropharyngeal squamous cell carcinoma. Int J Dent 2017:7. https://doi.org/10.1155/2017/5815493 CrossRef

20.

Sankaranarayanan R, Ramadas K, Amarasinghe H, Subramanian S, Johnson N (2015) Oral cancer: prevention, early detection, and treatment. In: Gelband H, Jha P, Sankaranarayanan R et al. (eds) Cancer: disease control priorities, Third Edition (Volume 3). The International Bank for Reconstruction and Development/The World Bank, Washington (DC). Chapter 5. https://www.ncbi.nlm.nih.gov/books/NBK343649/

21.

Kudo Y, Tada H, Fujiwara N, Tada Y, Tsunematsu T, Miyake Y, Ishimaru N (2016) Oral environment and cancer. Genes Environ 38:13. https://doi.org/10.1186/s41021-016-0042-z (eCollection 2016) CrossRefPubMedPubMedCentral

22.

Micheli A, Ciampichini R, Oberaigner W, Ciccolallo L, de Vries E, Izarzugaza I et al (2009) The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer 45(6):1017–1027. https://doi.org/10.1016/j.ejca.2008.11.008 CrossRefPubMed

23.

Levi S, Zini A, Fischman S, Czerninski R (2017) Epidemiology of oral, salivary gland and pharyngeal cancer in children and adolescents between 1970 and 2011. Oral Oncol 67:89–94. https://doi.org/10.1016/j.oraloncology.2017.02.010 (Epub 2017 Feb 21) CrossRefPubMed

24.

Granados-García M (2016) Oropharyngeal cancer: an emergent disease? Salud pública Méx 58(2):285–290. http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36342016000200285&lng=en. Accessed 21 July 2017

25.

Lacau St Guily J, Rousseau A, Baujat B, Périé S, Schultz P, Barry B, Dufour X, Malard O, Pretet JL, Clavel C, Birembaut P, Franceschi S, Papillophar Group (2017) Oropharyngeal cancer prognosis by tumour HPV status in France: the multicentric Papillophar study. Oral Oncol 67:29–36. https://doi.org/10.1016/j.oraloncology.2017.01.012 (E pub 2017 Feb 4) CrossRefPubMed

Title: Oral and oropharyngeal cancer in Colombia: an experience in a middle-income country cancer institute (2004–2013)
Authors: Constanza Pardo
Esther de Vries
Publication date: 01-06-2018
Publisher: Springer International Publishing
Published in: Oral Cancer / Issue 1-2/2018
Electronic ISSN: 2509-8837
DOI: https://doi.org/10.1007/s41548-018-0005-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Oral and oropharyngeal cancer in Colombia: an experience in a middle-income country cancer institute (2004–2013)

Abstract

Aims

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Aims

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1-2/2018

Comparison of the outcome of suprafacial and subfacial dissection of radial forearm in head and neck reconstruction

Tea, coffee, and head and neck cancer risk in a multicenter study in east Asia

Comparative histomorphometric study of intraepithelial papillary capillaries on leukoplakia with/without different dysplastic grading and squamous cell carcinoma of the oral mucosa

p53 and p16 expression in oral cavity squamous cell and basaloid squamous cell carcinoma

CD44 expression at the invasive tumor front: effect on patterning and prognosis in head and neck cancer

The oral pericommissural region: a distinct subsite—clinical features, histopathology, and treatment outcomes in 25 cases of squamous cancer